Error in Figure - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction to Figure 2A in the DROPROP Trial of Dexamethasone Eye Drops for Retinopathy of Prematurity

  • November 1, 2026

Share

  • 1

    Figure 2A in the DROPROP randomized clinical trial report contained incorrect bar heights.

  • 2

    The figure was corrected online after publication.

  • 3

    The trial evaluated dexamethasone eye drops to prevent treatment-requiring retinopathy of prematurity.

  • 4

    The corrected incidence of type 1 retinopathy of prematurity was 20% among dexamethasone recipients.

  • 5

    The corrected incidence was 38% among placebo recipients.

Original Source(s)

Error in Figure

  • November 1, 2026

Related Content

Vitreous cyst may hide behind chronic floaters

Imaging revealed a free-floating pigmented cyst after more than 20 years of symptoms.

Pneumatic retinopexy identification in electronic medical records using an on-premises large language model

FDA approves first at-home therapy for thyroid eye disease

The first at-home subcutaneous treatment for thyroid eye disease met its primary end point in 1 of 2 phase 3 trials.